Compare ARK Genomic Revolution ETF (ARKG) vs Materials Select Sector SPDR Fund (XLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Materials Select Sector SPDR Fund — how do they compare? ARK Genomic Revolution ETF trades at $40.8, while Materials Select Sector SPDR Fund trades at $50.51. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Materials Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| ARKG | XLB | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $53.62 |
52-Week Low | $23.09 | $42.23 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
XLB, the State Street Materials Select Sector SPDR ETF, trades at $50.89 with a 1.21% daily gain. Technical indicators signal a bearish trend with moving averages showing sell pressure, while oscillators remain neutral. Recent news highlights materials sector capital inflows and geopolitical impacts on supply chains. The ETF provides diversified exposure to U.S. materials companies, with a dividend scheduled for June 2026.
Outlook remains cautious due to bearish technicals and geopolitical sensitivity. Investment appeal hinges on sector earnings growth potential amid inflation and supply disruptions. Key risks include macroeconomic volatility and concentrated sector exposure, requiring careful risk assessment for equity investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Materials Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: chemicals; metals and mining; paper and forest products; containers and packaging; and construction materials. The fund is non-diversified.
Read more on XLB →
